🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary protocol objective is to assess the impact of substituting puls...
Status
Active Not Recruiting
Location
Medical College of Wisconsin
Start Date
2021-06-03
Trial ID
NCT04747145
Treatments Being Tested
The overall objective of this study is to preliminarily evaluate the effica...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-09-30
Trial ID
NCT07715097
Treatments Being Tested
Cilengitide 2000 mg flat i.v. twice weekly is administered over a period of...
Status
Unknown
Location
Royal North Shore Hospital
Start Date
2009-11
Trial ID
NCT01124240
Treatments Being Tested
The early clinical development paradigm for chemotherapeutic agents has sig...
Status
Terminated
Location
Washington University School of Medicine
Start Date
2015-12-03
Trial ID
NCT02510950
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as temozolomide, use different ...
Status
Terminated
Location
Mayo Clinic Scottsdale
Start Date
2004-01
Trial ID
NCT00068666
Treatments Being Tested
This is a prospective, single-center, open-label, 3+3 dose escalation Phase...
Status
Terminated
Location
MD Anderson Cancer Center
Start Date
2015-01-08
Trial ID
NCT02254954
Treatments Being Tested
The study is an open-label pilot study in newly diagnosed glioblastoma pati...
Status
Terminated
Location
University of California San Francisco
Start Date
2019-12-02
Trial ID
NCT03705351
Treatments Being Tested
This phase I trial will determine safety, dose-limiting toxicities (DLT) an...
Status
Completed
Location
Abramson Cancer Center of the University of Pennsylvania
Start Date
2009-04
Trial ID
NCT01020292
Treatments Being Tested
The goal of this single arm Phase I feasibility study is to investigate the...
Status
Terminated
Location
Columbia University Medical Center- Department of Radiation Oncology
Start Date
2018-03-19
Trial ID
NCT03246113
Treatments Being Tested
Glioblastomas (GBMs) are the most common malignant primary brain tumors. De...
Status
Completed
Location
Institut Catalá de Oncología Badalona/Hospital Germans Trias i Pujol
Start Date
2018-03-15
Trial ID
NCT03466450
Treatments Being Tested